INVESTMENT OFFERING

SAB Capital, on behalf of ownership, is pleased to exclusively offer 805 N. Wilson Avenue, a net-leased investment opportunity in Bristol, Pennsylvania, occupied by Labcorp (NYSE: LH) and enhanced by an on-site digital billboard leased to Outfront Media (NYSE: OUT). The property is strategically located just outside Philadelphia, immediately off Interstate 95, providing exceptional regional connectivity and visibility. The investment is distinguished by dual income streams backed by national, publicly traded tenants operating in resilient, growth-oriented industries. Labcorp occupies a 13,042-square-foot facility situated on 3.69 acres, while the digital billboard benefits from direct “eyes-on” exposure from Interstate 95, one of the most heavily trafficked corridors in the Northeast.

Labcorp, headquartered in Burlington, North Carolina, operates nearly 2,300 locations nationwide and is a leading provider of diagnostic and laboratory services. Outfront Media, headquartered in New York, New York, is among the largest out-of-home advertising operators in the United States, with more than 500,000 digital and static displays nationwide. Together, the tenants provide strong credit tenancy and long-term income durability. Both tenants recently executed new lease extensions, with Labcorp’s lease running through 2036, and Outfront Media’s lease extending through 2045, each with multiple extension options. The Labcorp lease features 2.0% annual rent increases throughout the base term and option period. The Outfront Media lease is structured as the greater of a minimum rent (which increases by $5,000 every five years, followed by 2.0% annual increases during the option period) or 30% of net revenue generated at the site. These structures provide predictable, inflation-hedged income with minimal landlord responsibilities.

This Labcorp location employs over 100 personnel and operates 24/7 as a full-service sample processing and logistics hub, supporting testing demand across Eastern Pennsylvania, Philadelphia, Southern New Jersey, and Northern Delaware. Increased utilization from a partner facility in Raritan, New Jersey further embeds this location within Labcorp’s regional network, reinforcing its mission-critical nature and long-term operational importance. This offering represents a rare opportunity to acquire a long-term, passive medical testing and logistics hub facility with supplemental advertising revenue in a premier U.S. metropolitan market. With durable cash flow, strong tenant credit, contractual rent growth, and intrinsic real estate value, 805 N. Wilson Avenue presents a compelling opportunity for passive investors and 1031 exchange buyers.